Salem Investment Counselors Inc Eli Lilly & CO Transaction History

Salem Investment Counselors Inc

$3.24 Billion
Q3 2024

A detailed history of Salem Investment Counselors Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Salem Investment Counselors Inc holds 70,881 shares of LLY stock, worth $53.4 Million. This represents 1.94% of its overall portfolio holdings.

Number of Shares

70,881

Previous 71,550 0.94%

Holding current value

$53.4 Million

Previous $64.8 Million 3.06%

% of portfolio

1.94%

Previous 2.11%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	SELL	$772.14 - $960.02 $516,561 - $642,253	-669 Reduced 0.94%	70,881 $62.8 Million
Q2 2024 Jul 11, 2024	SELL	$724.87 - $909.04 $571,197 - $716,323	-788 Reduced 1.09%	71,550 $64.8 Million
Q1 2024 Apr 11, 2024	BUY	$592.2 - $792.28 $1.16 Million - $1.55 Million	1,961 Added 2.79%	72,338 $56.3 Million
Q4 2023 Jan 16, 2024	BUY	$525.19 - $619.13 $3.15 Million - $3.71 Million	5,991 Added 9.3%	70,377 $41 Million
Q3 2023 Oct 04, 2023	BUY	$434.7 - $599.3 $3.14 Million - $4.33 Million	7,219 Added 12.63%	64,386 $34.6 Million
Q2 2023 Jul 19, 2023	SELL	$350.74 - $468.98 $12,275 - $16,414	-35 Reduced 0.06%	57,167 $26.8 Million
Q1 2023 May 11, 2023	SELL	$310.63 - $364.82 $295,098 - $346,579	-950 Reduced 1.63%	57,202 $19.6 Million
Q4 2022 Feb 15, 2023	BUY	$321.55 - $374.67 $530,557 - $618,205	1,650 Added 2.92%	58,152 $21.3 Million
Q3 2022 Nov 09, 2022	BUY	$296.48 - $337.87 $1.13 Million - $1.29 Million	3,818 Added 7.25%	56,502 $18.3 Million
Q2 2022 Aug 17, 2022	BUY	$278.73 - $327.27 $838,419 - $984,428	3,008 Added 6.06%	52,684 $17.1 Million
Q1 2022 May 16, 2022	BUY	$234.69 - $291.66 $246,189 - $305,951	1,049 Added 2.16%	49,676 $14.2 Million
Q4 2021 Feb 15, 2022	BUY	$224.85 - $279.04 $55,313 - $68,643	246 Added 0.51%	48,627 $13.4 Million
Q3 2021 Nov 15, 2021	BUY	$221.6 - $272.71 $726,848 - $894,488	3,280 Added 7.27%	48,381 $11.2 Million
Q2 2021 Aug 17, 2021	SELL	$180.55 - $233.54 $148,051 - $191,502	-820 Reduced 1.79%	45,101 $10.4 Million
Q1 2021 May 17, 2021	BUY	$164.32 - $212.72 $818,806 - $1.06 Million	4,983 Added 12.17%	45,921 $8.58 Million
Q4 2020 Feb 17, 2021	BUY	$130.46 - $172.63 $454,522 - $601,442	3,484 Added 9.3%	40,938 $6.91 Million
Q3 2020 Nov 13, 2020	SELL	$146.22 - $169.13 $124,871 - $144,437	-854 Reduced 2.23%	37,454 $5.54 Million
Q2 2020 Aug 13, 2020	BUY	$136.42 - $164.18 $377,883 - $454,778	2,770 Added 7.79%	38,308 $6.29 Million
Q1 2020 May 14, 2020	SELL	$119.05 - $147.35 $83,930 - $103,881	-705 Reduced 1.95%	35,538 $4.93 Million
Q4 2019 Feb 13, 2020	BUY	$106.92 - $132.43 $29,937 - $37,080	280 Added 0.78%	36,243 $4.76 Million
Q3 2019 Nov 13, 2019	SELL	$106.79 - $116.16 $10,679 - $11,616	-100 Reduced 0.28%	35,963 $4.02 Million
Q2 2019 Aug 14, 2019	BUY	$110.79 - $129.32 $373,140 - $435,549	3,368 Added 10.3%	36,063 $4 Million
Q1 2019 May 15, 2019	SELL	$111.31 - $131.02 $50,423 - $59,352	-453 Reduced 1.37%	32,695 $3.51 Million
Q4 2018 Feb 15, 2019	BUY	$105.9 - $118.64 $47,972 - $53,743	453 Added 1.39%	33,148 $3.84 Million
Q3 2018 Nov 14, 2018	SELL	$85.86 - $107.31 $17,086 - $21,354	-199 Reduced 0.6%	32,695 $3.51 Million
Q2 2018 Aug 15, 2018	SELL	$75.7 - $86.88 $182,815 - $209,815	-2,415 Reduced 6.84%	32,894 $2.75 Million
Q1 2018 May 15, 2018	SELL	$74.21 - $87.6 $1.43 Million - $1.69 Million	-19,295 Reduced 35.34%	35,309 $2.71 Million
Q4 2017 Feb 16, 2018	BUY	$81.94 - $87.89 $503,439 - $539,996	6,144 Added 12.68%	54,604 $4.61 Million
Q3 2017 Nov 16, 2017	BUY	$77.07 - $85.54 $3.73 Million - $4.15 Million	48,460	48,460 $4.17 Million

Others Institutions Holding LLY

# of Institutions

4,003

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $716B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Salem Investment Counselors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Salem Investment Counselors Inc with notifications on news.

Account

Salem Investment Counselors Inc Eli Lilly & CO Transaction History